Rapidly changing lifestyle drives the Saudi Arabia Blood Glucose Monitoring Devices Market, in forecast period, 2022-2026.
According to TechSci report on, “Saudi Arabia Blood Glucose Monitoring Devices Market By Product Type (Self Blood Glucose Monitoring Devices {Glucometers, Test Strips, Lancets} v/s Continuous Glucose Monitoring Devices {Sensors, Transmitters & Receivers, Integrated Insulin Pumps}) By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) By End User (Home Care Settings, Hospital, Others) By Region, Competition Forecast & Opportunities, 2026”,Saudi Arabia blood glucose monitoring devices market has shown promising growth in historical years until 2019 and is expected to continue its growth in upcoming forecast years 2021 to 2026. Saudi Arabia blood glucose monitoring devices market owes its growth to the factors like rising prevalence of the diabetes which is a chronic disease along with the increased awareness of these glucose monitoring devices among the diabetic patients. Moreover, governmental aid toward the reimbursement of the self-blood glucose monitoring diagnosis and treatment is anticipated to drive the market growth in the next five years.
Diabetes is a chronic condition that arises due to irregular blood sugar levels in the body. The treatment often involves insulin hormone treatment that regulates the sugar level in the human body. Blood glucose monitoring devices are used to consistently monitor the blood sugar level on daily, weekly, or continuous period. There are various types of devices available in the market that vary in sizes, prices, length of testing time, ease of accessibility.
In March 2020, the country was affected by the widespread of COVID-19 like the whole world. The economies were affecged and the whole world observed a complete lockdown. This affected the market although the healthcare industry was functional as per requirement. Due to the increased number of COVID positive patients, general patients were not able to obtain the due treatments. This fact multiplied the sales of self-monitoring devices many folds. Thus, it can be considered as one of the major factors that boosted the growth of Saudi Arabia blood glucose monitoring device market in the next five years.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on “Saudi Arabia Blood Glucose Monitoring Devices Market”
Saudi Arabia blood glucose monitoring device market segmentation is based on product type, application, end user, regional distribution, and competitional landscape. Based on application the market is further fragmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. The rising number of patients suffering from type 1 diabetes is driving the growth of the market. Therefore, type 1 diabetes is anticipated to dominate the market segment in the forecast period. Although, type 2 diabetes also requires a consistent monitoring of the blood sugar level, and therefore the segment is expected to hold a significant share of the market in the next five years.
Based on end user the market is further categorized into home care settings, hospitals, and others. Home care settings are expected to drive the market growth owing to the increased umber of patients that are self-reliant. Blood glucose monitor devices alerts the users regarding their irregular blood sugar or if there is any increase or decrease in the glucose level. Hospitals are often laced with the continuous blood glucose monitoring devices that are heavy duty and are not owned by singular patient due to its cost in-efficiency. Although hospitals with the government aid are able to afford the devices and thereby expected to hold significant market share in the market.
Some of the top players in the Saudi Arabia blood glucose monitoring device market are, Abbott Saudi Arabia, Roche Diagnostics Saudi Arabia LLC, Johnson & Johnson Medical Saudi Arabia Limited, Medtronic Saudi Arabia Co., Becton, Dickinson, and Company Saudi Arabia, Nipro Middle East FZE, Mediserv (B.Braun), VitalAire Arabia, Sanofi Aventis Arabia Co. Ltd, Bayer Saudi Arabia, among others. The companies are involving themselves into research and development for the methods of better quality, to provide better products.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7604
Customers can also request for 10% free customization on this report.
“Kingdom of Saudi Arabia supports a large population with disposable incomes. The increased concerns over the deteriorating lifestyle and thus caused diabetes and the related problem is driving the market growth. Moreover, the technologically advanced products can be seen as the future of the blood glucose monitoring devices. The devices with the smartphone compatibility is a major reason behind the surge in the demand. New players may form a partnership or work on the development of well researched and technologically advanced medical devices that will be cost effective as well as efficient with added functions,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Saudi Arabia Blood Glucose Monitoring Devices Market By Product Type (Self Blood Glucose Monitoring Devices {Glucometers, Test Strips, Lancets} v/s Continuous Glucose Monitoring Devices {Sensors, Transmitters & Receivers, Integrated Insulin Pumps}) By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) By End User (Home Care Settings, Hospital, Others) By Region, Competition Forecast & Opportunities, 2026” has evaluated the future growth potential of Saudi Arabia blood glucose monitoring device market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Saudi Arabia blood glucose monitoring devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]